Basic research for new drugs needs government subsidy.

The government subsidy over the pharmaceutical industry has supported more to commercialization of new products rather than the R&D for a new drug discovery without consideration of the national pharmaceutical technology level, said an expert.

Prof. Kim Sun-keun of Daejon University said in his research report submitted to the Ministry of Science and Technology titled "The government new rol...